echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Small and medium pharmaceutical enterprises should face up to their own problems and shape their own capabilities

    Small and medium pharmaceutical enterprises should face up to their own problems and shape their own capabilities

    • Last Update: 2013-10-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    With the continuous development of the pharmaceutical industry, many problems have gradually emerged, which has a serious impact on the development of pharmaceutical enterprises In the development of enterprises, the development of small and medium-sized pharmaceutical enterprises is facing many problems Small and medium-sized enterprises should face up to their own problems and carry out strategic planning As of August, 1319 sterile drug manufacturers in China have passed the new GMP certification, 365 of which have issued 483 certificates, accounting for 27% of the total 7%; of the 3839 non sterile drug manufacturers, 690 have passed the certification (excluding medical oxygen, Chinese herbal pieces and in vitro diagnostic reagents), and 846 certificates have been issued, with a passing rate of 18 0% First, let's look at the problems of small and medium-sized pharmaceutical enterprises It is understood that the main products of many small and medium-sized pharmaceutical enterprises are mainly generic products, with poor market competitiveness and low scale production capacity In this case, it is difficult for small and medium-sized pharmaceutical enterprises to gain advantages in simple product competition, which is the key issue for small and medium-sized pharmaceutical enterprises Zui However, there is another situation Some small and medium-sized pharmaceutical enterprises have a lot of reserve products These products can be selected through scientific screening to have a single product or even product portfolio with a negative effect However, small and medium-sized pharmaceutical enterprises lack professional talents or professional ideas If small and medium-sized pharmaceutical enterprises want to develop, they can not follow the popular route, but should be specialized or refined, and have their own unique development ideas Instead of fighting with competitors with non characteristic products, they should participate in the development of the industry with their own moldable competitive advantages At present, the pharmaceutical industry is in a stage of continuous development, the emergence of problems is inevitable Therefore, small and medium-sized pharmaceutical enterprises should formulate sound development strategies to promote the promotion of pharmaceutical investment and pharmaceutical agent work, so as to provide sufficient power for the development of the industry.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.